14th International Conference on the Chemistry of Antibiotics and other Bioactive Compounds, 13-16 October 2015, Texas, USA


Deepak Nijhawan, University of Texas, Southwestern Medical Center, USA

Deepak NijhawanMy training experience includes a PhD in Biochemistry (UTSW), a clinical fellowship in medical oncology, and a post-doctoral fellowship in cancer genomics at the Broad Institute/Dana Farber Cancer Institute. My lab is focused on using chemistry to identify new cancer targets by understanding the mode of action for small molecule cancer toxins. We have optimized both genetic and biochemical methods to efficiently and unambiguously identify the protein targets for cancer toxins.  Using these approaches, we have identified new strategies for targeted therapy as well as targets amongst protein families that would have otherwise be considered undruggable.

« Go Back

Organised by




Supporting Journal

Bioorganic & Medicinal Chemistry Letters